Five things for pharma marketers to know: Tuesday, January 24, 2017

Five things for pharma marketers to know: Tuesday, January 24, 2017

Endo settles pay-for-delay charges; Trump signs order withdrawing U.S. from TPP; administration considers Patrick Soon-Shiong for healthcare role

FDA guidance seeks to clarify pharma comms with payers

FDA guidance seeks to clarify pharma comms with payers

But it may also increase the reporting burden for drugmakers.

Five things for pharma marketers to know: Monday, January 23, 2017

Five things for pharma marketers to know: Monday, January 23, 2017

BMS and Ono settle Keytruda patent suit; PhRMA plans to release new campaign; Trump moves forward with plans to scale back the ACA

6 personalization practices from Walgreens' Balance Rewards program

6 personalization practices from Walgreens' Balance Rewards program

How the retail pharmacy chain uses customer data to make its marketing messages relevant.

Healthcare communicators track Obamacare repeal debate

Healthcare communicators track Obamacare repeal debate

Many healthcare comms leaders are paying close attention to the debate between "access" to healthcare versus making it a requirement, experts say.

Five things for pharma marketers to know: Friday, January 20, 2017

Five things for pharma marketers to know: Friday, January 20, 2017

Pharma among top sponsors of Trump inauguration parties; AstraZeneca exec to replace GSK president of global pharmaceuticals; EpiPen rival to relaunch

In draft guidance, the FDA defines appropriate off-label comms as being 'consistent' with the label

In draft guidance, the FDA defines appropriate off-label comms as being 'consistent' with the label

The regulator is providing examples of appropriate off-label communications.

Five things for pharma marketers to know: Thursday, January 19, 2017

Five things for pharma marketers to know: Thursday, January 19, 2017

The FDA releases three documents; PBM rebates eating into drugmaker revenue: PhRMA; most oncologists on Twitter receive money from pharma

Wunderman Health taps former Merkle exec as SVP of strategy and analytics

Wunderman Health taps former Merkle exec as SVP of strategy and analytics

Deborah Furey will lead the agency's pilot of a new personalized marketing offering.

MM&M opens nominations for Hall of Femme

MM&M opens nominations for Hall of Femme

MM&M last year named its inaugural class of 16 Femmes and 20 Women to Watch. Who should be considered for this year's list of breakthough women?

OPINION

Is Pharma Ready to Commit to the Startup World?

Email Newsletters